Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for Sudden cardiac death

American Journal of Cardiology

Volumn 115, Issue 11, 2015, Pages 1549-1554

  Kawai, Tsutomu ^a   Yamada, Takahisa ^a   Tamaki, Shunsuke ^a   Morita, Takashi ^a   Furukawa, Yoshio ^a   Iwasaki, Yusuke ^a   Kawasaki, Masato ^a   Kikuchi, Atsushi ^a   Kondo, Takumi ^a   Takahashi, Satoshi ^a   Ishimi, Masashi ^a   Hakui, Hideyuki ^a   Ozaki, Tatsuhisa ^a   Sato, Yoshihiro ^a   Seo, Masahiro ^a   Sakata, Yasushi ^b   Fukunami, Masatake ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCINTIANGIOGRAPHY; SENSITIVITY AND SPECIFICITY; SUDDEN CARDIAC DEATH; CHRONIC DISEASE; COMPLICATION; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC USE; EVALUATION STUDY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PROSPECTIVE STUDY; RISK; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; CHRONIC DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84929265758     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.058     Document Type: Article

References (23)

1. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
2. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, M.L. Andrews Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, J.H. Ip Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes III, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, M.O. Sweeney American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines Heart Rhythm Society 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 127 2013 e283 e352
5. A.J. Moss, H. Greenberg, R.B. Case, W. Zareba, W.J. Hall, M.W. Brown, J.P. Daubert, S. McNitt, M.L. Andrews, A.D. Elkin Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
6. M. Zecchin, M. Merlo, A. Pivetta, G. Barbati, C. Lutman, D. Gregori, L.V. Serdoz, S. Bardari, S. Magnani, A. Di Lenarda, A. Proclemer, and G. Sinagra How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?" Am J Cardiol 109 2012 729 735
7. P. Merlet, H. Valette, J.L. Dubois-Randé, D. Moyse, D. Duboc, P. Dove, M.H. Bourguignon, C. Benvenuti, A.M. Duval, D. Agostini, D. Loisance, A. Castaigne, and A. Syrota Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471 477
8. T. Yamada, T. Shimonagata, M. Fukunami, K. Kumagai, H. Ogita, A. Hirata, M. Asai, N. Makino, H. Kioka, H. Kusuoka, M. Hori, and N. Hoki Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study J Am Coll Cardiol 41 2003 231 238
9. H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart 93 2007 1213 1218
10. A.F. Jacobson, R. Senior, M.D. Cerqueira, N.D. Wong, G.S. Thomas, V.A. Lopez, D. Agostini, F. Weiland, H. Chandna, J. Narula ADMIRE-HF Investigators Myocardial 123I-mIBG imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF study J Am Coll Cardiol 55 2010 2212 2221
11. Y. Kuramoto, T. Yamada, S. Tamaki, Y. Okuyama, T. Morita, Y. Furukawa, K. Tanaka, Y. Iwasaki, T. Yasui, H. Ueda, T. Okada, M. Kawasaki, W.C. Levy, I. Komuro, and M. Fukunami Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure Am J Cardiol 107 2011 1185 1190
12. M.I. Anastasiou-Nana, J.V. Terrovitis, T. Athanasoulis, L. Karaloizos, A. Geramoutsos, L. Pappa, E.P. Tsagalou, S. Efentakis, and J.N. Nanas Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 96 2005 427 431
13. T. Nakata, K. Nakajima, S. Yamashina, T. Yamada, M. Momose, S. Kasama, T. Matsui, S. Matsuo, M.I. Travin, and A.F. Jacobson A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure JACC Cardiovasc Imaging 6 2013 772 784
14. K. Nakajima, T. Nakata, T. Yamada, S. Yamashina, M. Momose, S. Kasama, T. Matsui, S. Matsuo, M.I. Travin, and A.F. Jacobson A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 1I-metaiodobenzylguanidine imaging Eur J Nucl Med Mol Imaging 41 2014 1673 1682
15. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
16. H. Ogita, T. Shimonagata, M. Fukunami, K. Kumagai, T. Yamada, Y. Asano, A. Hirata, M. Asai, H. Kusuoka, M. Hori, and N. Hoki Prognostic significance of cardiac I-123 metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study Heart 86 2001 656 660
17. A. Foti, S. Kimura, V. DeQuattro, and D. Lee Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine Clin Chem 33 1987 2209 2213
18. Y. Kanda Investigation of the freely available easy-to-use software "EZR" for medical statistics Bone Marrow Transplant 48 2013 452 458
19. R. Arora, K.J. Ferrick, T. Nakata, R.C. Kaplan, M. Rozengarten, F. Latif, K. Ng, V. Marcano, S. Heller, J.D. Fisher, and M.I. Travin I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator J Nucl Cardiol 10 2003 121 131
20. D. Nagahara, T. Nakata, A. Hashimoto, T. Wakabayashi, M. Kyuma, R. Noda, S. Shimoshige, K. Uno, K. Tsuchihashi, and K. Shimamoto Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function J Nucl Med 49 2008 225 233
21. M. Koutelou, A. Katsikis, P. Flevari, G. Theodorakis, E. Livanis, M. Georgiadis, V. Voudris, and D. Kremastinos Predictive value of cardiac autonomic indexes and MIBG washout in ICD recipients with mild to moderate heart failure Ann Nucl Med 23 2009 677 684
22. K. Nishisato, A. Hashimoto, T. Nakata, T. Doi, H. Yamamoto, D. Nagahara, S. Shimoshige, S. Yuda, K. Tsuchihashi, and K. Shimamoto Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs J Nucl Med 51 2010 1241 1249
23. M.J. Boogers, C.J. Borleffs, M.M. Henneman, R.J. van Bommel, J. van Ramshorst, E. Boersma, P. Dibbets-Schneider, M.P. Stokkel, E.E. van der Wall, M.J. Schalij, and J.J. Bax Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2010 2769 2777